A female-founded and led, San Francisco based biotech company, Nalu Bio is committed to transforming health and wellness to enhance quality of life and address chronic health issues. Our proprietary AI platform accelerates the development of prescription products by leveraging cannabinoid scaffolds to generate and validate novel compounds that offer safer alternatives to opioids. This process reduces preclinical development timelines by years and saves millions. Targeting the endocannabinoid system (ECS)—the body’s natural balancing system that regulates metabolism, gastrointestinal functions, inflammation, cognition, and immunity—enables us to address the top health challenges with minimal side effects at global scale.